Improving the Accelerated Pathway to Cancer Drug Approvals
- PMID: 27898987
- DOI: 10.1001/jamainternmed.2016.7777
Improving the Accelerated Pathway to Cancer Drug Approvals
Comment on
-
Quality of Life, Overall Survival, and Costs of Cancer Drugs Approved Based on Surrogate Endpoints.JAMA Intern Med. 2017 Feb 1;177(2):276-277. doi: 10.1001/jamainternmed.2016.7761. JAMA Intern Med. 2017. PMID: 27898978 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources